Although novel biomarkers, such as neutrophil gelatinase-associated lipocalin and cystatin C, have been identified as independent predictors of AKI and are superior to conventional biomarkers, sCr continues to be a more valuable and accepted tool for AKI diagnosis [18]. Here, CST3 is linked to acute kidney injury.